Bronowicki, Jean-Pierre

Publishing since 1994 (Senior)

Has published 67 publications in 17 years

Number of publications published per year by Bronowicki, Jean-Pierre. (Source : PubMed)

Distribution of publications types for Bronowicki, Jean-Pierre. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Diago M, Shiffman ML, Bronowicki JP, Zeuzem S, Rodriguez-Torres M, Pappas SC, Tietz A, Nelson DR. Identifying hepatitis C virus genotype 2/3 patients who can receive a 16-week abbreviated course of peginterferon alfa-2a (40KD) plus ribavirin.  Hepatology  2010  
•  Chevaux JB, Bigard MA, Bensenane M, Oussalah A, Jarlot S, Belle A, Nani A, Bronowicki JP, Peyrin-Biroulet L. Inflammatory bowel disease and hepatitis B and C.  Gastroenterol. Clin. Biol.  2009;33;12  
•  Chevaux JB, Bigard MA, Bensenane M, Oussalah A, Jarlot S, Belle A, Nani A, Bronowicki JP, Peyrin-Biroulet L. [Inflammatory bowel disease and hepatitis B and C]  Gastroenterol. Clin. Biol.  2009;33;12  
•  Chevaux JB, Nani A, Oussalah A, Venard V, Bensenane M, Belle A, Gueant JL, Bigard MA, Bronowicki JP, Peyrin-Biroulet L. Prevalence of hepatitis B and C and risk factors for nonvaccination in inflammatory bowel disease patients in Northeast France.  Inflamm. Bowel Dis.  2009  
•  Sturm N, Bronowicki JP, Maynard-Muet M, Tran A, Heluwaert F, Plages A, Zarski JP. Metformin plus pentoxifylline versus prescriptive diet in non-alcoholic steatohepatitis (NASH): a randomized controlled pilot trial.  Gastroenterol. Clin. Biol.  2009;33;10-11  
•  Barbare JC, Bouché O, Bonnetain F, Dahan L, Lombard-Bohas C, Faroux R, Raoul JL, Cattan S, Lemoine A, Blanc JF, Bronowicki JP, Zarski JP, Cazorla S, Gargot D, Thevenot T, Diaz E, Bastie A, Aparicio T, Bedenne L. Treatment of advanced hepatocellular carcinoma with long-acting octreotide: a phase III multicentre, randomised, double blind placebo-controlled study.  Eur. J. Cancer  2009;45;10  
•  Hézode C, Forestier N, Dusheiko G, Ferenci P, Pol S, Goeser T, Bronowicki JP, Bourlière M, Gharakhanian S, Bengtsson L, McNair L, George S, Kieffer T, Kwong A, Kauffman RS, Alam J, Pawlotsky JM, Zeuzem S. Telaprevir and peginterferon with or without ribavirin for chronic HCV infection.  N. Engl. J. Med.  2009;360;18  
•  Bronowicki JP, Nani A, Barraud H. [Management of chronic hepatitis C which failed to respond to previous treatment]  Gastroenterol. Clin. Biol.  2009;33;4  
•  Peyrin-Biroulet L, Cadranel JF, Nousbaum JB, Oussalah A, Seddik M, Canva V, Cortot A, Sogni P, Gueant JL, Bigard MA, Roblin X, Bronowicki JP. Interaction of ribavirin with azathioprine metabolism potentially induces myelosuppression.  Aliment. Pharmacol. Ther.  2008;28;8  
•  Bronowicki JP, Abdelmouttaleb I, Peyrin-Biroulet L, Venard V, Khiri H, Chabi N, Amouzou EK, Barraud H, Halfon P, Sanni A, Bigard MA, Le Faou A, Guéant JL. Methylenetetrahydrofolate reductase 677 T allele protects against persistent HBV infection in West Africa.  J. Hepatol.  2008;48;4  

[ See timeline ] [ See all publications ]